SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Reports of Jensen Huangs relationship with a person alleged to be a Chinese intelligence asset, and Nvidias board investigation, are driving concern about national-security exposure, governance and Huangs future as CEO. Traders are split between viewing the controversy as a serious overhang and treating it as a temporary headline-driven dip while Nvidias business remains intact.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing attention after quarterly results disappointed some traders on sales and execution, while the company also reported that ANKTIVA plus BCG met the primary endpoint in its BCG-nave bladder-cancer trial, a potential label-expansion catalyst. The community is split between concerns about commercial momentum, BCG supply and dilution, and optimism about the trial result and international rollout.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics Q3 report and raised full-year revenue outlook, driven by BRIUMVI growth, are the main focus. Traders largely welcomed the results, while some cautioned about a possible sell-the-news reaction; buyout speculation remains unconfirmed, and the subcutaneous BRIUMVI readout is viewed as a future catalyst.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedixs agreement to acquire Heron Therapeutics commercial assets, including four marketed products, is driving attention. Traders are weighing the deals potential to broaden revenue and create synergies against concerns about the cash-and-stock consideration and managements capital allocation.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention as its ETH-treasury-linked shares sell off amid weakness in Ethereum and broader crypto markets; traders also point to Binance-hack concerns as a source of sector pressure. The community is split between viewing the discount to asset value and potential buybacks as an opportunity, and worrying that continued ETH weakness, dilution, and managements execution could keep the stock lagging.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa is the main focus, with traders watching for the FDAs decision on whether to accept it and the review timeline, including whether priority review is granted. The community is split between seeing the filing and the drugs clinical data as supportive catalysts and worrying about regulatory risk, competitionincluding Mercks HS dataand MoonLakes ability to commercialize on its own.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,200,877.25744775. The last known price of Ethereum is 2,141.49627095 USD and is down -4.09 over the last 24 hours. It is currently trading on 14297 active market(s) with $9,084,277,576.13 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is under pressure amid a broad crypto selloff, with traders discussing heavy selling and leveraged-long liquidations; explanations tied to macro uncertainty or Nvidia headlines remain speculative. Sentiment is divided between dip-buyers expecting a rebound and bearish traders warning that support may give way.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is drawing attention as traders await the planned AXPAXLI NDA filing for wet AMD and updates on its timing around the Q3 earnings call. Some see the positive SOL-1 results and long-acting treatment potential as supportive, while others are frustrated by the wait and question whether the filing will lift shares amid clinical and commercial uncertainty.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais earnings update and outlook for faster growth in its cloud business are drawing attention, while the proposed convertible-note offering has raised questions about financing its AI infrastructure buildout. Traders are split between optimism about AI and Anthropic-related demand and concern about upfront investment, dilution, and whether that growth will translate into returns.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline alongside a broader crypto selloff has traders focused on whether it will break below the $1 level, with some warning of further downside and others buying or holding the dip. The community also cites uncertainty around crypto legislation and a lack of fresh catalysts, though these are discussed as possible headwinds rather than confirmed causes.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


sunwinsad

Sunwin